Abstract
Cocaine, like most other drugs of abuse, exerts long lasting changes in gene expression in the reward circuitry of the brain. This resultant remodelled reward circuitry is considered to underlie drug addiction and relapse. In recent years, genome-wide expression studies and epigenomic analysis of the affected regions in the reward circuitry have identified molecular changes associated with the structural remodeling of the circuitry. In particular, application of gene expression microarray and chromatin immunoprecipitation (ChIP) coupled to microarray (ChIP-chip) or sequencing (ChIP-seq) has provided unprecedented insights into the neural and behavioral adaptations in nucleus accumbens (NAc), the critical substrate of the reward circuitry, in cocaine addiction. Genome level expression profiling and epigenomic analysis leading to the recent advances in our understanding of cocaine-induced neural and behavioral adaptations are reviewed here. We examine the convergence of transcriptomic and epigenomic evidence, and discuss about emerging drug target candidates in cocaine-addiction.
Keywords: Addiction, nucleus accumbens, reward circuitry, gene regulatory networks, microarray, ChIP-chip, ChIP-Seq, RNA-Seq, mesolimbic dopamine, cocaine addiction, transcription, oligonucleotide microarrays, post-translational modifications, epigenetic regulatory mechanisms, accumbens genome
Current Psychopharmacology
Title:Insight into Cocaine-Induced Neural and Behavioral Adaptations Using Genome-Wide Expression Profiling and Epigenomic Analysis
Volume: 1
Author(s): Sumana Chakravarty and Arvind Kumar
Affiliation:
Keywords: Addiction, nucleus accumbens, reward circuitry, gene regulatory networks, microarray, ChIP-chip, ChIP-Seq, RNA-Seq, mesolimbic dopamine, cocaine addiction, transcription, oligonucleotide microarrays, post-translational modifications, epigenetic regulatory mechanisms, accumbens genome
Abstract: Cocaine, like most other drugs of abuse, exerts long lasting changes in gene expression in the reward circuitry of the brain. This resultant remodelled reward circuitry is considered to underlie drug addiction and relapse. In recent years, genome-wide expression studies and epigenomic analysis of the affected regions in the reward circuitry have identified molecular changes associated with the structural remodeling of the circuitry. In particular, application of gene expression microarray and chromatin immunoprecipitation (ChIP) coupled to microarray (ChIP-chip) or sequencing (ChIP-seq) has provided unprecedented insights into the neural and behavioral adaptations in nucleus accumbens (NAc), the critical substrate of the reward circuitry, in cocaine addiction. Genome level expression profiling and epigenomic analysis leading to the recent advances in our understanding of cocaine-induced neural and behavioral adaptations are reviewed here. We examine the convergence of transcriptomic and epigenomic evidence, and discuss about emerging drug target candidates in cocaine-addiction.
Export Options
About this article
Cite this article as:
Chakravarty Sumana and Kumar Arvind, Insight into Cocaine-Induced Neural and Behavioral Adaptations Using Genome-Wide Expression Profiling and Epigenomic Analysis, Current Psychopharmacology 2012; 1 (4) . https://dx.doi.org/10.2174/2211556011201040332
DOI https://dx.doi.org/10.2174/2211556011201040332 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Current Pharmaceutical Design New Peptidic GnRH Antagonists Offer a Broad Range of Therapeutic Applications
Letters in Drug Design & Discovery The Hormetic Role of Dietary Antioxidants in Free Radical-Related Diseases
Current Pharmaceutical Design Functions of Ghrelin in Brain, Gut and Liver
CNS & Neurological Disorders - Drug Targets Molecular Mechanisms Regulating the Mitochondrial Targeting of Microsomal Cytochrome P450 EnzymesMolecular Mechanisms Regulating the Mitochondrial Targeting of Microsomal Cytochrome P450 Enzymes
Current Drug Metabolism Rheumatoid Foot and Ankle Surgery
Current Rheumatology Reviews Kisspeptin: Paving the Way to a New Therapeutic Avenue in Reproduction
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Treatment of Cardiovascular Risk Factors in Women
Current Medicinal Chemistry Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease
Current Pharmaceutical Design Potential Effect of Angiotensin II Receptor Blockade in Adipose Tissue and Bone
Current Pharmaceutical Design Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems
CNS & Neurological Disorders - Drug Targets Application of Human Laboratory Models to Pharmacotherapy Development for Alcohol Dependence
Current Pharmaceutical Design Animal Models of Xenobiotic Receptors
Current Drug Metabolism Recent Developments on Thiourea Based Anticancer Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry Steroid Hormones and Sleep Regulation
Mini-Reviews in Medicinal Chemistry Neonatal Brain Hemorrhage (NBH) of Prematurity: Translational Mechanisms of the Vascular-Neural Network
Current Medicinal Chemistry Current and Future Applications of Probiotics
Current Nutrition & Food Science Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology Omega-3 Fatty Acids: Role in the Prevention and Treatment of Psychiatric Disorders
Current Psychiatry Reviews